380 related articles for article (PubMed ID: 19549223)
1. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection.
Heath CH; Slavin MA; Sorrell TC; Handke R; Harun A; Phillips M; Nguyen Q; Delhaes L; Ellis D; Meyer W; Chen SC;
Clin Microbiol Infect; 2009 Jul; 15(7):689-93. PubMed ID: 19549223
[TBL] [Abstract][Full Text] [Related]
2. Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning.
Tintelnot K; Wagner N; Seibold M; de Hoog GS; Horré R
Mycoses; 2008 Sep; 51 Suppl 3():11-6. PubMed ID: 18782237
[TBL] [Abstract][Full Text] [Related]
3. Human and animal isolates of Pseudallescheria boydii and Scedosporium species, from Melbourne, Australia, 1977-1995.
Maslen M; Peel M
Mycoses; 2011 Sep; 54(5):442-9. PubMed ID: 20492531
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.
Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2007 Feb; 51(2):748-51. PubMed ID: 17101671
[TBL] [Abstract][Full Text] [Related]
5. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
Husain S; Muñoz P; Forrest G; Alexander BD; Somani J; Brennan K; Wagener MM; Singh N
Clin Infect Dis; 2005 Jan; 40(1):89-99. PubMed ID: 15614697
[TBL] [Abstract][Full Text] [Related]
6. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors?
Blyth CC; Middleton PG; Harun A; Sorrell TC; Meyer W; Chen SC
Med Mycol; 2010 Nov; 48 Suppl 1():S37-44. PubMed ID: 21067328
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients.
Johnson LS; Shields RK; Clancy CJ
Transpl Infect Dis; 2014 Aug; 16(4):578-87. PubMed ID: 24962102
[TBL] [Abstract][Full Text] [Related]
8. Infection with Scedosporium apiospermum and S. prolificans, Australia.
Cooley L; Spelman D; Thursky K; Slavin M
Emerg Infect Dis; 2007 Aug; 13(8):1170-7. PubMed ID: 17953087
[TBL] [Abstract][Full Text] [Related]
9. Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum.
Delhaes L; Harun A; Chen SC; Nguyen Q; Slavin M; Heath CH; Maszewska K; Halliday C; Robert V; Sorrell TC; ; Meyer W
Emerg Infect Dis; 2008 Feb; 14(2):282-90. PubMed ID: 18258122
[TBL] [Abstract][Full Text] [Related]
10. Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates.
Lackner M; Rezusta A; Villuendas MC; Palacian MP; Meis JF; Klaassen CH
Mycoses; 2011 Oct; 54 Suppl 3():12-21. PubMed ID: 21995658
[TBL] [Abstract][Full Text] [Related]
11. Septic arthritis due to Scedosporium apiospermum: case report and review.
Tirado-Miranda R; Solera-Santos J; Brasero JC; Haro-Estarriol M; Cascales-Sánchez P; Igualada JB
J Infect; 2001 Oct; 43(3):210-2. PubMed ID: 11798262
[TBL] [Abstract][Full Text] [Related]
12. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999.
Idigoras P; Pérez-Trallero E; Piñeiro L; Larruskain J; López-Lopategui MC; Rodríguez N; González JM
Clin Infect Dis; 2001 Jun; 32(11):E158-65. PubMed ID: 11340550
[TBL] [Abstract][Full Text] [Related]
13. Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification.
Bronnimann D; Garcia-Hermoso D; Dromer F; Lanternier F; ;
Med Mycol; 2021 May; 59(5):486-497. PubMed ID: 33037432
[TBL] [Abstract][Full Text] [Related]
14. Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis.
Harun A; Gilgado F; Chen SC; Meyer W
Med Mycol; 2010 Nov; 48 Suppl 1():S70-6. PubMed ID: 21067333
[TBL] [Abstract][Full Text] [Related]
15. Case reports. Transient colonization with Scedosporium prolificans. Report of four cases in Madrid.
del Palacio A; Garau M; Amor E; Martinez-Alonso I; Calvo T; Carrillo-Muñoz A; Guarro J
Mycoses; 2001; 44(7-8):321-5. PubMed ID: 11714069
[TBL] [Abstract][Full Text] [Related]
16. Lymphadenitis caused by Scedosporium apiospermum in an immunocompetent patient.
Kiraz N; Gülbas Z; Akgün Y; Uzun O
Clin Infect Dis; 2001 Feb; 32(3):E59-61. PubMed ID: 11170973
[TBL] [Abstract][Full Text] [Related]
17. Scedosporium aurantiacum is as virulent as S. prolificans, and shows strain-specific virulence differences, in a mouse model.
Harun A; Serena C; Gilgado F; Chen SC; Meyer W
Med Mycol; 2010 Nov; 48 Suppl 1():S45-51. PubMed ID: 21067330
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of Scedosporium prolificans against Pseudallescheria boydii and Scedosporium apiospermum by semiautomated repetitive sequence-based PCR.
Steinmann J; Schmidt D; Buer J; Rath PM
Med Mycol; 2011 Jul; 49(5):475-83. PubMed ID: 21108573
[TBL] [Abstract][Full Text] [Related]
19. Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease--a diagnostic and therapeutic challenge.
Tammer I; Tintelnot K; Braun-Dullaeus RC; Mawrin C; Scherlach C; Schlüter D; König W
Int J Infect Dis; 2011 Jun; 15(6):e422-9. PubMed ID: 21511507
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.
Cuenca-Estrella M; Alastruey-Izquierdo A; Alcazar-Fuoli L; Bernal-Martinez L; Gomez-Lopez A; Buitrago MJ; Mellado E; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2008 Mar; 52(3):1136-9. PubMed ID: 18195067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
